Barcelona based, a biopharmaceutical company that focused on Skin Health, Almirall has announced the appointment of Gianfranco Nazzi as its new CEO and Executive Director.
The company in its filing said, “The Boards of Directors has announced the appointment of Mr. Gianfranco Nazzi as CEO and Executive Director of the Board of Directors effective May 1, 2021.”
Mr. Nazzi joins Almirall from Teva Pharmaceuticals Industries Ltd, where he has most recently been serving as Executive Vice President of the International Markets Region and as a member of the Teva Executive Committee. He has held roles of increasing responsibility and geographic scope based in Israel and the Netherlands.
He held the position of Senior Vice President Specialty Medicines Europe and President and CEO Growth Markets Region.
Speaking on the appointment of Gianfranco Almirall, Jorge Gallardo, Chairman of the Board and President of Almirall, said, “I´m very pleased to announce that the Board of Directors has agreed to appoint Gianfranco Nazzi. Mr. Nazzi is a trusted leader in the Pharma industry and brings with him a wealth of experience in areas key to the success and growth of Almirall, in the US, Europe, and Emerging Markets. I am convinced he will bring what is needed to develop Almirall to the next level.”
“I am excited to join Almirall and its talented team of professionals. The company’s focus on putting patients at the center of all that they do is inspiring and I am sure that I will be able to continue to support them and provide them with novel and value-added solutions and treatments to improve their lives. I am committed to this mission and I know that, together with the team, we will achieve great milestones in the near future”, Gianfranco Nazzi said.
